Xu Y, Zacharias U, Peraldi M N, He C J, Lu C, Sraer J D, Brass L F, Rondeau E
INSERM U 64, Tenon Hospital, Paris, France.
Am J Pathol. 1995 Jan;146(1):101-10.
Thrombin exerts procoagulant effects and has also many cellular effects mediated by cell surface receptors. A functional thrombin receptor from human platelets has been cloned and sequenced. In the present study, by reverse transcription and polymerase chain reaction, using specific primers designed from the thrombin receptor cDNA sequence, we show that the mRNA encoding for this receptor can be amplified from freshly isolated human glomeruli obtained by microdissection of normal kidney cortex. By immunohistochemistry using a specific monoclonal antibody, ATAP2, directed against the extracellular N-terminus of this receptor, we find that this functional thrombin receptor is constitutively expressed in the normal human kidney. The three glomerular cell types, endothelial, mesangial, and epithelial cells, were positively stained, as were the endothelial cells of renal arteries, arterioles, venules, and peritubular capillaries. Occasionally, interstitial cells and smooth muscle cells in the media of renal arteries were also stained. Proximal and distal tubular cells were not stained. By in situ hybridization, using a digoxigenin-labeled cDNA probe specific for thrombin receptor, the thrombin receptor mRNA was found to have the same distribution as the thrombin receptor protein detected by immunohistochemistry. A lighter staining of glomerular endocapillary cells was observed in cases of thrombotic microangiopathy and extracapillary glomerulonephritis, two renal diseases associated with in situ thrombin generation and fibrin formation. In one case of thrombotic microangiopathy, we observed an increase in thrombin receptor mRNA. This suggests that thrombin receptor protein is not always correlated with thrombin receptor mRNA level. Internalization and degradation of thrombin receptor protein have been demonstrated in vitro and could also occur after activation in vivo. This is the first demonstration of the constitutive expression of the functional thrombin receptor in the human kidney. These results suggest that thrombin may exert glomerular and vascular effects within the kidney in normal and in pathological conditions.
凝血酶具有促凝血作用,还可通过细胞表面受体介导产生多种细胞效应。一种来自人血小板的功能性凝血酶受体已被克隆和测序。在本研究中,我们通过逆转录和聚合酶链反应,使用根据凝血酶受体cDNA序列设计的特异性引物,表明可从通过显微切割正常肾皮质获得的新鲜分离的人肾小球中扩增出编码该受体的mRNA。通过使用针对该受体细胞外N端的特异性单克隆抗体ATAP2进行免疫组织化学分析,我们发现这种功能性凝血酶受体在正常人体肾脏中组成性表达。三种肾小球细胞类型,即内皮细胞、系膜细胞和上皮细胞呈阳性染色,肾动脉、小动脉、小静脉和肾小管周围毛细血管的内皮细胞也是如此。偶尔,肾动脉中层的间质细胞和平滑肌细胞也被染色。近端和远端肾小管细胞未被染色。通过原位杂交,使用针对凝血酶受体的地高辛标记cDNA探针,发现凝血酶受体mRNA的分布与免疫组织化学检测到的凝血酶受体蛋白相同。在血栓性微血管病和毛细血管外肾小球肾炎这两种与原位凝血酶生成和纤维蛋白形成相关的肾脏疾病中,观察到肾小球毛细血管内皮细胞染色较轻。在一例血栓性微血管病中,我们观察到凝血酶受体mRNA增加。这表明凝血酶受体蛋白并不总是与凝血酶受体mRNA水平相关。凝血酶受体蛋白的内化和降解已在体外得到证实,在体内激活后也可能发生。这是首次证明功能性凝血酶受体在人肾脏中的组成性表达。这些结果表明,凝血酶可能在正常和病理条件下对肾脏内的肾小球和血管产生影响。